.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Novartis
Cantor Fitzgerald
Federal Trade Commission
Daiichi Sankyo
US Army
Deloitte
Baxter
Medtronic

Generated: September 24, 2017

DrugPatentWatch Database Preview

POTIGA Drug Profile

« Back to Dashboard

Which patents cover Potiga, and what generic Potiga alternatives are available?

Potiga is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in POTIGA is ezogabine. One supplier is listed for this compound. Additional details are available on the ezogabine profile page.

Summary for Tradename: POTIGA

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list70
Clinical Trials: see list2
Patent Applications: see list431
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:POTIGA at DailyMed

Pharmacology for Tradename: POTIGA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
POTIGA
ezogabine
TABLET;ORAL022345-001Jun 10, 2011RXYesNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
POTIGA
ezogabine
TABLET;ORAL022345-004Jun 10, 2011RXYesYes► Subscribe► Subscribe► Subscribe
Glaxosmithkline
POTIGA
ezogabine
TABLET;ORAL022345-002Jun 10, 2011RXYesNo► Subscribe► Subscribe► Subscribe
Glaxosmithkline
POTIGA
ezogabine
TABLET;ORAL022345-003Jun 10, 2011RXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Chubb
AstraZeneca
McKesson
US Army
Fuji
Novartis
Cantor Fitzgerald
Farmers Insurance
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot